GoodRx shares rose 1.5% in premarket trading Tuesday after the healthcare company said it will offer a 30-day supply of oral ...

The safety and effectiveness of QSYMIA in combination with other products intended for weight loss, including prescription ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

For some people, diet, and exercise are not enough to lose weight and keep it off. This is where weight loss medication, ...

Treatment with Qysmia did not demonstrate a pressor effect. The Food and Drug Administration (FDA) has updated the prescribing information for Qsymia (phentermine ...

The once-daily pill is currently covered by 81% of commercial healthcare plans and is indicated for long-term use. QSYMIA is designed to help patients manage hunger and reduce cravings throughout ...

Topamax contains the active ingredient topiramate. This is also one of the active ingredients in Qsymia, an FDA-approved drug for long-term weight management. (The other active ingredient in ...

The once-daily pill is currently covered by 81% of commercial healthcare plans and is indicated for long-term use. QSYMIA is designed to help patients manage hunger and reduce cravings throughout the ...

Collaborative telehealth platform will provide patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing their ...

QSYMIA is designed to help patients manage hunger ... and the simplicity of taking a daily pill can make it easier to adhere to treatment regimens. "Obesity medications are life-changing for ...

Investing.com -- GoodRx shares rose 1.5% in premarket trading Tuesday after the healthcare company said it will offer a 30-day supply of oral weight management drug Qsymia for $149. The stock lost ...